Lilly Asia Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
BlossomHill TherapeuticsDec 2023SEC filingmedium confidence
BiotechSan Diego, US
JINGRONG JEAN CUI(Executive Officer, Director)YISHAN LI(Executive Officer, Director)Jingrong Jean Cui(Executive Officer, Director)Li Peter Yishan(Executive Officer, Director)
BoardGEORGE LEE(Director)CARL GORDON(Director)
Board seatHongbo Lu· per SEC Form D · $100M raise · filed Jan 2024
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.